What are the available payment terms?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Sost Good Price Gastrodin powder

Name: Sost Good Price Gastrodin powder
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 2031735665

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$451.00-452.00

1 KG

Sample price:US$451.80/kg.Request sample

Product profile

Customization

Available

CAS No.

62499-27-8

Formula

C13H18O7

Resource

Natural

Transport Package

25 Kg/Carton Outside and Double Food Plastic Bags

Specification

98%

Trademark

SOST

Origin

China

Production Capacity

1000 Kg/Momth

Key features

Neuroprotective Benefits: Reduces neuroinflammation and protects dopaminergic neurons from damage.

Cognitive Improvement: Increases BDNF and GDNF factors to enhance learning and memory.

Cardiovascular Support: Helps lower blood pressure and improves myocardial microcirculation.

Anti-Liver Fibrosis: Demonstrates effective activity in reducing liver fibrosis and oxidative stress.

Natural Skin Lightening: Inhibits tyrosinase activity to reduce melanin synthesis for cosmetic use.

Epilepsy Management: Prevents seizures by reducing extracellular glutamate levels in the brain.

Comprehensive Safety: Meets strict standards for heavy metals, pesticides, and microbiological tests.

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.66h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.